Foster Jonathan P.
Chief Financial Officer
Foster Jonathan P. has filed 4 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Oct 17, 2026.
On the most recent filing, Foster Jonathan P. is listed as Chief Financial Officer at Moleculin Biotech, Inc. Inside the rolling window, Foster Jonathan P. reported 1 open-market purchase in MBRX and no open-market sales.
Companies traded
Other insiders at MBRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Foster Jonathan P. made?
Foster Jonathan P. has filed 4 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.
Which companies does Foster Jonathan P. trade?
Foster Jonathan P. has filed SEC Form 4 disclosures for 1 company, including MBRX.
When was Foster Jonathan P.'s most recent SEC Form 4 filing?
Foster Jonathan P.'s most recent SEC Form 4 filing on Tracefour is dated Oct 17, 2026.
What is Foster Jonathan P.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Foster Jonathan P. is listed as Chief Financial Officer.